Anti Diabetic effect of CL 316,243 (A β3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ghorbani, Masoud ^a,b   Shafiee Ardestani, Mehdi ^a   Gigloo, Sedigheh Hatami ^a   Cohan, Reza Ahangari ^a   Inanlou, Davoud Nouri ^a   Ghorbani, Peyman ^c  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; NONHUMAN; OBESITY; RAT; WHITE ADIPOSE TISSUE;

ABDOMINAL FAT; ADIPOSE TISSUE, WHITE; ADRENERGIC BETA-AGONISTS; ANIMALS; BLOOD GLUCOSE; BLOTTING, NORTHERN; BODY WEIGHT; DIOXOLES; DOWN-REGULATION; FATTY ACIDS; GENE EXPRESSION; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, ADRENERGIC, BETA-3; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS; RODENTIA;

EID: 84867136992     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045874     Document Type: Article

References (17)

1. Hotamisligil G, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
2. Lang C, Dobrescu C, Bagby G, (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43.
3. Kanety H, Feinstein R, Papa M, Hemi R, Karasik, (1995) A Tumor necrosis factor-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Journal of Biological Chemistry 270: 23780.
4. Hotamisligil G, Murray D, Choy L, Spiegelman B, (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proceedings of the National Academy of Sciences 91: 4854.
5. Ghorbani M, Himms-Hagen J, (1997) Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. International journal of obesity 21: 465-475.
6. Largis E, Burns M, Muenkel H, Dolan J, Claus T, (1994) Antidiabetic and antiobesity effects of a highly selective ß3-adrenoceptor agonist (CL 316,243). Drug development research 32: 69-76.
7. Hotamisligil G, Spiegelman B, (1993) Through thick and thin: wasting, obesity, and TNF alpha. Cell 73: 625-627.
8. Matthews D, Hosker J, Rudensk A, Naylor B, Treacher D, et al. (1985) Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
9. Howard G, Bergman R, Wagenknecht LE, Haffner SM, Savage PJ, et al. (1998) Comparison with the. Annals of epidemiology 8: 358-369.
10. Hotamisligil G, Peraldi P, Budavari A, Ellis R, White M, et al. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-$alpha$-and obesity-induced insulin resistance. Science 271: 665.
11. Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P, (1993) Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem 5; 268 (10):: 6823-6.
12. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, et al. (1994) Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134: 264.
13. Hotamisligil G, Shargil N, Spiegelman B, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87.
14. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, et al. (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366: 740-742.
15. Hyunsook K, Pennisi PA, Gavrilova O, Pack S, Jou W, et al. (2006) Effect of adipocyte β3-adrenergic receptor activation on the type 2 diabetic MKR mice. American Journal of Physiology- Endo 290: 6.
16. D'Allaire F, Atgié C, Mauriege P, Simard P, Bukowiecki L, (1995) Characterization of beta 1-and beta 3-adrenoceptors in intact brown adipocytes of the rat. British journal of pharmacology 114: 275.
17. Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, et al. (2008) The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice. Eur J Pharmacol 584 (1):: 202-6.